Cat. No. |
Product Name |
Information |
PC-73321 |
CFT7455
IKZF1/3 degrader
|
Cemsidomide (CFT7455) is a highly potent and selective degarder of IKZF1/3 with cereblon binding IC50 of 0.4 nM and picomolar DC50. |
PC-73316 |
CFT8634
BRD9 BiDAC degrader
|
CFT-8634 (CFT8634) is a potent, selective, orally bioavailable BRD9 BiDAC degrader with DC50 of 3 nM, high selectivity over BRD4 abd BRD7. |
PC-73296 |
QC-01-175
Tau PROTAC
|
QC-01-175 is a hetero-bifunctional molecule designed to engage both tau and Cereblon (CRBN) to trigger tau ubiquitination and proteasomal degradation (tau PROTAC). |
PC-73287 |
HDAC8 PROTAC 1
HDAC8 degrader
|
HDAC8 PROTAC 1 is a first-in-class proteolysis targeting chimera (PROTAC) for selective degradation of histone deacetylase 8 (HDAC8). |
PC-73152 |
ACBI1
SMARCA2/4 PROTAC
|
ACBI1 is a potent and cooperative degrader (PROTAC) of BAF ATPase subunits SMARCA2, SMARCA4 and PBRM1 with DC50 of 6 nM, 11 nM and 32 nM, respectively. |
PC-72930 |
YTK-105 linker conjugate 1
AUTOTAC conjugate
|
YTK-105 linker conjuate 1 is a PEG linker added to p62-ZZ ligand YTK-105 for AUTOTAC design. |
PC-72929 |
YOK-2204 linker conjugate 1
AUTOTAC conjugate
|
YOK-2204 linker conjuate 1 is a PEG linker added to p62-ZZ ligand YOK-2204 for AUTOTAC design. |
PC-72928 |
YOK-1304 AUTOTAC intermidate 1
AUTOTAC conjugate
|
YOK-1304 AUTOTAC intermidate 1 is an intermidate for AUTOTAC design. |
PC-72927 |
p62-ZZ ligand YTK-105
p62-ZZ ligand
|
YTK-105 is a small molecule p62-ZZ domain ligand, activate p62-dependent selective macroautophag, used for AUTOTAC design. |
PC-72926 |
p62-ZZ ligand YOK-2204
p62-ZZ ligand
|
YOK-2204 is a small molecule p62-ZZ domain ligand, activate p62-dependent selective macroautophag, used for AUTOTAC design. |
PC-72925 |
p62-ZZ ligand YOK-1304
p62-ZZ ligand
|
YOK-1304 is a small molecule p62-ZZ domain ligand, activate p62-dependent selective macroautophag, used for AUTOTAC design. |
PC-72911 |
GNE-987
BET degrader
|
GNE-987 (GNE987) is a highly potent chimeric BET degrader, exhibits BRD4 degradation activity in EOL-1 AML cell line with DC50 of 30 pM. |